Company logo

RCKT - Rocket Pharmaceuticals, Inc.

NASDAQ -> Healthcare -> Biotechnology
Cranbury, United States
Type: Equity

RCKT price evolution
RCKT
(in millions $) 31 Mar 2024 31 Dec 2023 30 Sep 2023 30 Jun 2023
Current assets
Cash $37.17 $57.81 $227.57 $46.98
Short term investments $295.04 $317.27 $211.51 $261.96
Net receivables
Inventory
Total current assets $345.16 $378.22 $446.87 $312.07
Long term investments $34.32
Property, plant & equipment $88.08 $87.59 $85.68 $82.92
Goodwill & intangible assets $64.3 $64.3 $64.3 $64.88
Total noncurrent assets $154.28 $188.12 $151.9 $149.71
Total investments $295.04 $351.59 $211.51 $261.96
Total assets $499.44 $566.34 $598.76 $461.78
Current liabilities
Accounts payable $30.09 $45.79 $30.62 $31.35
Deferred revenue
Short long term debt $2.87 $2.72 $2.85 $2.99
Total current liabilities $32.96 $48.51 $33.48 $34.35
Long term debt $23.08 $22.33 $22.33 $22.39
Total noncurrent liabilities $24.98 $25.26 $24.2 $24.46
Total debt $25.95 $25.04 $25.18 $25.39
Total liabilities $57.94 $73.77 $57.68 $58.81
Shareholders' equity
Retained earnings -$1021.42 -$959.37 -$899.71 -$837.81
Other shareholder equity -$0.14 $0.32 -$0.51 -$0.72
Total shareholder equity $441.5 $492.57 $541.09 $402.97
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $57.81 $142.47 $234.49 $299.12
Short term investments $317.27 $215.88 $156.05 $185.62
Net receivables
Inventory
Total current assets $378.22 $364.06 $392.06 $487.35
Long term investments $34.32 $43.28
Property, plant & equipment $87.59 $77.64 $72.35 $70.64
Goodwill & intangible assets $64.3 $64.88 $30.82 $30.82
Total noncurrent assets $188.12 $187.75 $104.96 $103.48
Total investments $351.59 $259.15 $156.05 $185.62
Total assets $566.34 $551.81 $497.02 $590.82
Current liabilities
Accounts payable $45.79 $36.66 $19.61 $25.47
Deferred revenue
Short long term debt $2.72 $2.51 $2.55 $7.14
Total current liabilities $48.51 $39.17 $22.17 $32.62
Long term debt $22.33 $19.27 $20.05 $54.55
Total noncurrent liabilities $25.26 $22.95 $20.13 $54.69
Total debt $25.04 $22.87 $22.6 $61.7
Total liabilities $73.77 $62.12 $42.3 $87.31
Shareholders' equity
Retained earnings -$959.37 -$713.77 -$491.91 -$322.84
Other shareholder equity $0.32 -$0.36 -$0.16 -$0.04
Total shareholder equity $492.57 $489.69 $454.72 $503.52
(in millions $) 31 Mar 2024 31 Dec 2023 30 Sep 2023 30 Jun 2023
Revenue
Total revenue
Cost of revenue
Gross Profit
Operating activities
Research & development $45.23 $41.74 $46.84 $51.38
Selling, general & administrative $22.15 $21.54 $18.59 $17.37
Total operating expenses $67.38 $63.28 $65.43 $68.76
Operating income -$67.38 -$63.28 -$65.43 -$68.76
Income from continuing operations
EBIT -$61.58 -$59.19 -$61.43 -$65.23
Income tax expense
Interest expense $0.47 $0.47 $0.47 $0.47
Net income
Net income -$62.05 -$59.66 -$61.9 -$65.7
Income (for common shares) -$62.05 -$59.66 -$61.9 -$65.7
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue
Cost of revenue
Gross Profit
Operating activities
Research & development $186.34 $165.57 $125.48 $106.38
Selling, general & administrative $73.32 $58.77 $41.77 $27.92
Total operating expenses $259.66 $224.34 $167.25 $134.3
Operating income -$259.66 -$224.34 -$167.25 -$134.3
Income from continuing operations
EBIT -$243.72 -$220 -$166.09 -$132.73
Income tax expense
Interest expense $1.88 $1.86 $2.98 $6.97
Net income
Net income -$245.59 -$221.86 -$169.07 -$139.7
Income (for common shares) -$245.59 -$221.86 -$169.07 -$139.7
(in millions $) 31 Mar 2024 31 Dec 2023 30 Sep 2023 30 Jun 2023
Net income -$62.05 -$59.66 -$61.9 -$65.7
Operating activities
Depreciation $2.25 $1.94 $1.76 $1.73
Business acquisitions & disposals
Stock-based compensation $10.25 $9.93 $10.32 $10.24
Total cash flows from operations -$56.86 -$29.34 -$57.15 -$50.87
Investing activities
Capital expenditures -$2.04 -$4.65 -$4.66 -$4.15
Investments $37.07 -$136.16 $52.91 $35.35
Total cash flows from investing $35.03 -$140.81 $48.25 $31.21
Financing activities
Dividends paid
Sale and purchase of stock $1.18 $0.39 $189.49 $0.18
Net borrowings
Total cash flows from financing $1.18 $0.39 $189.49 $0.18
Effect of exchange rate
Change in cash and equivalents -$20.64 -$169.75 $180.59 -$19.48
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income -$245.59 -$221.86 -$169.07 -$139.7
Operating activities
Depreciation $7.1 $6.27 $5.37 $1.15
Business acquisitions & disposals $42.73
Stock-based compensation $39.41 $31.01 $29.24 $18.57
Total cash flows from operations -$194.92 -$178.14 -$121.16 -$74.64
Investing activities
Capital expenditures -$16.47 -$8.62 -$7.71 -$29.06
Investments -$81.59 -$103.43 $26.57 -$67.53
Total cash flows from investing -$98.07 -$69.33 $18.85 -$96.59
Financing activities
Dividends paid
Sale and purchase of stock $208.4 $155.29 $37.68 $283.84
Net borrowings -$0.24
Total cash flows from financing $208.4 $155.29 $37.68 $282.99
Effect of exchange rate
Change in cash and equivalents -$84.58 -$92.18 -$64.63 $111.76
Fundamentals
Market cap $1.99B
Enterprise value $1.98B
Shares outstanding 90.65M
Revenue $0.00
EBITDA -$239.76M
EBIT -$247.44M
Net Income -$249.31M
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio -7.98
EV/Sales N/A
EV/EBITDA -8.26
EV/EBIT -8.00
P/S ratio N/A
P/B ratio 4.51
Book/Share 4.87
Cash/Share 0.41
EPS -$2.75
ROA -46.90%
ROE -53.10%
Debt/Equity 0.15
Net debt/EBITDA -0.09
Current ratio 10.47
Quick ratio 10.47